AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (552)	8/20/1997 4:47:00 PM
From: david thor	of 2173

Hi Henry, I just took a very small position in AMLN after their drop, for reasons that make sense to me. What I would like to know is how you can be so sure that LGND will be successful in their work. As an investor, I know I could never know a company well enough unless I worked for them - at the top. Biotechs are pure speculation. I first looked into AMLN long before Johnson & Johnson's $120M investment, but didn't know enough about them. Oddly, the recent drop is the only reason I visited the stock again and ended up purchasing a small amount which I expect will be long-term. Having done some study on Amylin's recent past, what could you tell me and the others here that would be convincing evidence that LGND does not have the problems that Amylin has now? I've read your posts and they have been informative, but I've been burned before by rollercoaster stocks. BTW, diabetes has run in my family, so I sure hope that relief is in sight no matter who "builds a better drug". Regards, Dave

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next